Ibrance 75 MG capsule 21S
Ended Awarded Last action
- Contract number
- SPE2DR26FS8XW
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3 Part of Cencora, Inc.
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $8,561
Award facts
- Contract value 100% obligated
- $8,561.41 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a delivery order valued at $8,561.41 to AmerisourceBergen Drug Corp for the supply of Ibrance 75 mg capsules (21-count packages) on January 30, 2026, with an ultimate completion date of February 23, 2026. This firm fixed-price, non-set-aside contract is being performed at the awardee's corporate office location in Conshohocken, Pennsylvania. The delivery order is issued under AmerisourceBergen's parent company Cencora, Inc.'s larger Indefinite Delivery Contract with DLA Troop Support Medical, a comprehensive global pharmaceutical support vehicle valued at $999,999,999.00 and extending through December 2031.
AmerisourceBergen serves as a critical pharmaceutical distributor for federal military and veteran healthcare systems, supplying a broad portfolio of prescription medications, specialty drugs, vaccines, and medical supplies through multiple federal contract vehicles. As a major for-profit pharmaceutical distribution company, AmerisourceBergen competes on a full and open basis for federal procurement requirements and has demonstrated capability in fulfilling diverse medical commodity needs across multiple therapeutic domains. This specific delivery order for Ibrance, an oncology medication, represents a routine task order execution under the company's overarching DLA pharmaceutical supply agreement supporting military treatment facilities and government healthcare institutions.
Quick answers
Who was awarded contract SPE2DR26FS8XW?
SPE2DR26FS8XW was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on January 30, 2026.
How much is contract SPE2DR26FS8XW worth?
The government has obligated $8,561 on SPE2DR26FS8XW.
Is contract SPE2DR26FS8XW an order under another contract?
Yes. SPE2DR26FS8XW is a delivery order under SPE2DR25D3021, an indefinite delivery contract.
Was contract SPE2DR26FS8XW competed?
The extent of competition for SPE2DR26FS8XW was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award